Jefferies Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
RG
ACA
PAI
Jefferies Group's FOLD Position: Q4 2021 in Review
Jefferies Group sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 25,829 shares — an estimated $247K sold.
Jefferies Group first reported a position in FOLD in Q3 2014 and held it in 13 quarters. The position peaked at $729K in Q2 2019. 223 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.
- Jefferies Group reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
- Jefferies Group sold 25,829 Amicus Therapeutics shares in Q4 2021, an estimated $247K.
- Jefferies Group first reported a position in Amicus Therapeutics in Q3 2014 and held it in 13 quarters.
- Jefferies Group's Amicus Therapeutics position peaked at $729K in Q2 2019.
- 223 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.
Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.